Pathological response and tumor stroma immunogenic features predict long-term survival in non-small cell lung cancer after neoadjuvant chemotherapy.

Shuaibo WangXujie SunJiyan DongLi LiuHao ZhaoRenda LiZhenlin YangNa ChengYalong WangLi FuHang YiZhuoheng LvHuandong HuoDonghui JinYousheng MaoLin Yang

Published in: Cellular oncology (Dordrecht) (2024)

NPG integrated with nS can provide a simple, practical, and robust approach that may allow for better stratification of patients when evaluating neoadjuvant chemotherapy in clinical practice.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
end stage renal disease
clinical practice
newly diagnosed
chronic kidney disease
peritoneal dialysis
squamous cell carcinoma
prognostic factors
radiation therapy
early stage
patient reported outcomes